Drug Type Recombinant LBP |
Synonyms STACT-TREX1 |
Target |
Action agonists, inhibitors |
Mechanism STING agonists(Stimulator of interferon genes agonists), TREX1 inhibitors(Three prime repair exonuclease 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | United States | 01 Jul 2019 |





